Lorch, M; Pfirrmann, M; Fabisch, C; Oberle, L; Kohn, D; Kohlbrenner, K; Brümmendorf, TH; Burchert, A; Krause, SW; le Coutre, P; Hänel, M; Franke, GN; Stegelmann, F; Radsak, MP; Kunzmann, ; Jost, PJ; Baerlocher, GM; Mayer, J; Hofmann, WK; Hochhaus, A; Saussele, S.
Health-related quality of life (HRQoL) effects of pegylated Interferon α2b (PEG-IFN) in Nilotinib (NIL)-based treatment of chronic myeloid leukemia (CML)
ONCOL RES TREAT. 2023; 46: 279-280.
[Poster]
Web of Science